Form 4: IGM Biosciences CEO Fred Schwarzer Reports Stock Transactions
SEC Form 4 Filing
CEO Fred Schwarzer reports acquisition of restricted stock units (RSUs) and disposition of common stock.
Summary
- On March 26, 2024, Fred Schwarzer, CEO and President of IGM Biosciences, reported acquiring 38,583 shares of common stock in the form of restricted stock units (RSUs).
- These RSUs were granted in lieu of an earned cash bonus for performance in fiscal year 2023.
- Each RSU represents a contingent right to receive one share of IGM Biosciences' Common Stock.
- 100% of the RSUs will vest in December 2024, contingent upon continued service.
- Schwarzer also reported disposing of 196,718 shares of common stock.
- Following these transactions, Schwarzer directly owns 255,234 shares of IGM Biosciences common stock.
- Additionally, 196,718 shares are indirectly held by the Schwarzer Family Trust.
Sentiment
Score: 5
Explanation: The document presents factual information about stock transactions. The sentiment is neutral as the acquisition of RSUs is balanced by the disposition of shares.
Positives
- The acquisition of RSUs by the CEO could be seen as a positive sign, indicating confidence in the company's future performance.
Negatives
- The disposition of 196,718 shares of common stock by the CEO could be interpreted negatively by some investors.
Risks
- The vesting of the RSUs is contingent upon the Reporting Person remaining a service provider through the vesting date, introducing a risk factor related to continued employment.
- The disposition of shares could be perceived as a lack of confidence in the company's future prospects.
Future Outlook
The document does not contain explicit forward-looking statements, but the vesting of RSUs in December 2024 suggests an expectation of continued service by the CEO.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. The acquisition of RSUs in lieu of a cash bonus is a common practice in executive compensation.
Stakeholder Impact
- The reported transactions may influence investor sentiment and potentially impact the company's stock price.
Key Dates
| Date | Description |
|---|---|
| 04/05/2018 | Date of the Schwarzer Family Trust U/A DTD. |
| 03/26/2024 | Date of the reported transactions: acquisition of RSUs and disposition of common stock. |
| 03/28/2024 | Date of signature by power of attorney. |
| December 2024 | Vesting date for 100% of the acquired RSUs. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.